The Pathophysiological Significance of Dual Inhibition of IL-17A and IL-17F in Psoriatic Arthritis and Axial Spondyloarthritis
Inhibiting both IL-17A and IL-17F signifies not only a significant therapeutic advancement but also a vital strategy towards overcoming the limitations of our current armamentarium in achieving deeper and more sustained remission in SpA. Future studies and long-term data will be essential in determining the position of dual IL-17A/F inhibitors within treatment guidelines.
Authors
- Andreas V. Goules (ORCID: https://orcid.org/0000-0003-4343-0396)
- O. Katsouli
- V. Lainis
- Panayiotis G. Vlachoyiannopoulos
Institutions
- National and Kapodistrian University of Athens (GR)
Publication Details
- Journal
- Mediterranean Journal of Rheumatology
- Published
- 2026-01-21
- DOI
- https://doi.org/10.31138/mjr.020925.aar
- Primary Topic
- Spondyloarthritis Studies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00